Dr. Jänne is the Director of the Lower Center for Thoracic Oncology at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.
A breakthrough technology that transformed the existing random and intuitive method, by making the targets and candidates for new drugs visually understandable.